Capital International, Inc./CA/ - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital International, Inc./CA/ ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$3,461,000
-34.1%
98,882
+0.8%
0.04%
-40.6%
Q2 2020$5,248,000
+122.8%
98,137
+47.8%
0.06%
+60.0%
Q1 2020$2,355,000
-22.5%
66,379
+4.4%
0.04%
-4.8%
Q4 2019$3,037,000
-74.3%
63,597
-82.6%
0.04%
-76.4%
Q3 2019$11,830,000
+391.3%
365,138
+656.3%
0.18%
+6.0%
Q2 2019$2,408,000
+75.3%
48,277
+136.9%
0.17%
+3.1%
Q1 2019$1,374,000
+39.4%
20,376
-4.7%
0.16%
+20.7%
Q4 2018$986,000
-40.2%
21,3760.0%0.14%
-37.2%
Q3 2018$1,649,000
+27.9%
21,376
+39.7%
0.22%
+9.1%
Q2 2018$1,289,000
-2.7%
15,300
-5.6%
0.20%
+2.6%
Q1 2018$1,325,000
-15.9%
16,200
-41.2%
0.19%
-17.9%
Q4 2017$1,575,000
-42.2%
27,550
-32.5%
0.23%
-41.2%
Q3 2017$2,723,000
-14.2%
40,800
-33.9%
0.40%
-12.3%
Q2 2017$3,174,000
-36.7%
61,700
-28.1%
0.45%
-25.6%
Q1 2017$5,011,000
+39.5%
85,800
-0.3%
0.61%
+36.5%
Q4 2016$3,593,000
+13.6%
86,100
+43.7%
0.45%
+18.9%
Q3 2016$3,164,000
+16.0%
59,900
-8.0%
0.38%
+14.6%
Q2 2016$2,727,000
+14.2%
65,100
+10.7%
0.33%
+25.2%
Q1 2016$2,387,000
-62.4%
58,800
-39.9%
0.26%
-53.5%
Q4 2015$6,356,000
+23.9%
97,900
+34.7%
0.56%
+21.0%
Q3 2015$5,132,000
-27.6%
72,700
+13.9%
0.47%
-8.3%
Q2 2015$7,091,000
+15.5%
63,800
-2.0%
0.51%
+10.0%
Q1 2015$6,139,000
-17.7%
65,100
-2.3%
0.46%
-10.5%
Q4 2014$7,462,00066,6000.52%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders